Tuesday, 19 January 2016

NEJM Week of 15th October 2015 (#12)

Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors

Week of the October 15th 2015 (#12)
University of Notre Dame Australia
(Fremantle campus)

Articles Recommended by and for Medical Students

Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia


EDITORIAL

No End to Uncertainty about Inhaled Glucocorticoids in Preterm Infants

The Editorial summarises the article well. In essence, this is large, multinational, randomized, placebo-controlled trial treating extremely preterm infants (< 28 weeks gestation) with inhaled corticosteroid (budesonide) or placebo to determine if the risk of bronchopulmonary dysplasia was reduced. The results of the study were positive (27.8 % in the budesonide group versus 38% in the placebo group) and fewer closures of PDAs and reintubation. However the overall mortality rate was increased in the budesonide group over the placebo group (16.9% versus 13.6%) in a condition where the mortality rate is normally high. These results are well discussed in the Editorial.
Recommended learning: Clinical entities associated with prematurity

ORIGINAL ARTICLE

Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Year


EDITORIAL

Neonatal Hypoglycemia Studies — Is There a Sweet Story of Success Yet?

This article and Editorial raise as many questions as they appear to answer regarding the diagnosis of neonatal hypoglycaemia and its management. The authors monitor not only blood glucose intermittently but also continuous interstitial glucose (every 5 minutes) by a subcutaneous probe (for up to seven days). Hypoglycaemia in the neonate is defined as a glucose level less than 2.6 mmol/L, whereas in children and adults the level is accepted as less than 3.3-why?
This is a prospective cohort study of neonates with a gestational age of at least 35 weeks and who were considered at risk for developing hypoglycaemia. Hypoglycaemia was treated to maintain a BSL above 2.2 mmol/L. Overall 53% of participants developed hypoglycaemia and nearly 25% had hypoglycaemia only recognised initially by the subcutaneous probe. Even with treatment (they also trialled an oral glucose gel), 25% of infants had at least five hours of low glucose levels.
In this cohort, maintaining a BSL >2.2 mmol/L for 48 hours after birth, at two years of age there was no significant neurocognitive impairment (advanced testing of executive function, visual and processing and vision) demonstrated. They raise the possibility that BSLs at the high end of normal or rapid correct of low BSLs to higher levels may be associated with a poorer neurological outcome. Stay tuned.
Recommended learning: Types of hypoglycaemia in the neonate, especially transient hypoglycaemia and its clinical recognition.

ORIGINAL ARTICLE

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas

This is a large randomized, double-blind, placebo-controlled trial in which patients who had a colonic polyp removed were treated with vitamin D (1000 IU/day), calcium carbonate (1200 mg/day) or placebo in all combinations to determine if there were any effect(s) upon the recurrence of future polyps. Over a 3-5 year follow-up period, there was no change in the recurrence rate at the doses of vitamin D or calcium tested.
Recommended learning: Review the epidemiology and genetics of colorectal cancer.

CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

Case 32-2015 — A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure

http://www.nejm.org/doi/full/10.1056/NEJMcpc1503830

 

This CPC reviews the causes of severe, progressive pneumonia in a patient who lived on the East Coast of the US and who had travelled in the recent past.

 

When you consider the reasoning of a CPC discussant, you find that the least likely diagnoses are considered first, and excluded, with the provisional diagnosis reached at the end in a climax – it appears on the surface to be a diagnosis of exclusion.

 

However, this is not how the clinician reasons when reaching a diagnosis in clinical practice. The clinician considers first the most likely diagnosis, based upon the history, the physical examination and the experience of the physician. In this week’s case, the diagnosis should have been apparent at the onset. As you take the history and perform the physical examination, the clinician should be considering the differential diagnoses and arranging them in a priority list with the provisional diagnosis at the top of the list at the end. With each diagnosis, the clinician is continually assessing the pros and cons of each.

 

Recommended learning:  Because of rapid travel, this patient could have quite easily presented in any city in the world. Be aware of the differing geographic prevalence of infectious diseases and how these need to be assessed in the traveller. In this case, an overview of fungal infections in the non-immunosuppressed patient from various areas in the US (in general: West coast – coccidioidomycosis; Mid-west – histoplasmosis; East coast – blastomycosis).

 

IMAGES IN CLINICAL MEDICINE

Bursitis and Tenosynovitis Due to Mycobacterium avium Complex

http://www.nejm.org/doi/full/10.1056/NEJMicm1500800


The MAC complex should always be considered as a cause for a subacute monoarticular arthritis and/or tenosynovitis in the immunosuppressed patient (in this case the patient had dermatomyositis and had been on long-term corticosteroids).

Recommended learning: Review dermatomyositis and atypical mycobacterial infections.